Soliton (NSDQ:SOLY) said today that it raised $9 million in a private placement for the acoustic tattoo removal aid it’s developing.
Houston-based Soliton, which licenses its technology from the University of Texas, is develop a rapid acoustic pulse device that’s designed to make tattoo-removal lasers more effective. The device won 510(k) clearance from the FDA last month. The company said the $9.5 million placement was led by a $5 million investment by its largest backer, Remeditex Ventures.